Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|April 5, 2020
Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor TherapiesCarlos Hernandez, Hugo Arasanz, Luisa Chocarro, et al.
International Journal of Molecular Sciences|August 23, 2020
PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade ImmunotherapyAna Bocanegra, Ester Blanco, Gonzalo Fernandez-Hinojal, et al.
International Journal of Molecular Sciences|November 11, 2022
Systemic CD4 Immunity and PD-L1/PD-1 Blockade ImmunotherapyDavid Escors, Ana Bocanegra, Luisa Chocarro, et al.
International Journal of Molecular Sciences|February 11, 2023
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid TumorsEster Blanco, Luisa Chocarro, Leticia Fernández-Rubio, et al.
Diagnostic Cytopathology|November 24, 2025
A Case Report of Undifferentiated NUT Carcinoma of Lung Diagnosed by EBUS-FNA: If You Hear Hoofbeats Do Not Assume They Are HorsesTania Labiano, Martín Fuentes, Yessica Rodriguez, et al.
Melanoma Management|September 8, 2018
Immunotherapy in malignant melanoma: recent approaches and new perspectivesHugo Arasanz, Alejandra Lacalle, Maria José Lecumberri, et al.
International Journal of Molecular Sciences|June 28, 2023
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung CancerHugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, et al.
Frontiers in Pharmacology|April 23, 2020
Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?Luisa Chocarro de Erauso, Miren Zuazo, Hugo Arasanz, et al.
Biomedicines|December 23, 2022
Cutting-Edge CAR Engineering: Beyond T CellsLuisa Chocarro, Ester Blanco, Leticia Fernández-Rubio, et al.
Pageof 5